M. Knight

730 total citations
10 papers, 595 citations indexed

About

M. Knight is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, M. Knight has authored 10 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Oncology. Recurrent topics in M. Knight's work include Viral Infections and Immunology Research (3 papers), interferon and immune responses (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). M. Knight is often cited by papers focused on Viral Infections and Immunology Research (3 papers), interferon and immune responses (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). M. Knight collaborates with scholars based in United Kingdom, United States and Israel. M. Knight's co-authors include Ian M. Kerr, P.J. Cayley, Robert H. Silverman, C. S. Gilbert, Daniel H. Wreschner, R.E. Brown, Bert M. Tolbert, E. M. Baker, Russell W. Carlson and Mancourt Downing and has published in prestigious journals such as Nature, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

M. Knight

10 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Knight United Kingdom	8	321	153	91	68	64	10	595
T. Miwa Japan	15	316 1.0×	131 0.9×	164 1.8×	25 0.4×	41 0.6×	40	902
Andrew M. Parrott United States	16	732 2.3×	138 0.9×	127 1.4×	53 0.8×	35 0.5×	30	1.1k
Jesper Lykkegaard Karlsen Denmark	8	471 1.5×	60 0.4×	61 0.7×	38 0.6×	52 0.8×	12	694
Marek Gniazdowski Poland	13	774 2.4×	81 0.5×	18 0.2×	53 0.8×	21 0.3×	37	992
Hans Faillard Germany	15	568 1.8×	99 0.6×	58 0.6×	124 1.8×	15 0.2×	54	781
Yves Plancke France	16	447 1.4×	73 0.5×	124 1.4×	71 1.0×	6 0.1×	35	662
J. Pudles France	15	407 1.3×	31 0.2×	50 0.5×	57 0.8×	11 0.2×	54	717
Giuseppe Infusini Australia	17	394 1.2×	103 0.7×	43 0.5×	61 0.9×	24 0.4×	24	770
Charles A. Dekker United States	14	691 2.2×	62 0.4×	27 0.3×	60 0.9×	7 0.1×	21	877
Thomas Akompong United States	12	210 0.7×	102 0.7×	46 0.5×	72 1.1×	8 0.1×	19	580

Countries citing papers authored by M. Knight

Since Specialization

Citations

This map shows the geographic impact of M. Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Knight more than expected).

Fields of papers citing papers by M. Knight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Knight. The network helps show where M. Knight may publish in the future.

Co-authorship network of co-authors of M. Knight

This figure shows the co-authorship network connecting the top 25 collaborators of M. Knight. A scholar is included among the top collaborators of M. Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Knight. M. Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Silverman, Robert H., P.J. Cayley, Daniel H. Wreschner, et al.. (1983). 2-5A(pppA2'p5'A2'p5'A) in interferon-treated encephalomyocarditis virus-infected mouse L-cells.. PubMed. 41. 479–86. 1 indexed citations

Kerr, Ian M., P.J. Cayley, Robert H. Silverman, & M. Knight. (1982). The antiviral action of interferon. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 299(1094). 59–67. 12 indexed citations

Cayley, P.J., M. Knight, & Ian M. Kerr. (1982). Virus-mediated inhibition of the ppp(A2′p)n A system and its prevention by interferon. Biochemical and Biophysical Research Communications. 104(2). 376–382. 54 indexed citations

Silverman, Robert H., P.J. Cayley, M. Knight, C. S. Gilbert, & Ian M. Kerr. (1982). Control of the ppp(A2′p)_nA System in HeLa Cells. European Journal of Biochemistry. 124(1). 131–138. 102 indexed citations

Knight, M., Daniel H. Wreschner, Robert H. Silverman, & Ian M. Kerr. (1981). Radioimmune and radiobinding assays for A2'p5'A2'p5'A, pppA2'p5'A, and related oligonucleotides.. PubMed. 79(Pt B). 216–27. 49 indexed citations

Hovanessian, Ara G., R.E. Brown, E. M. Martin, et al.. (1981). [24] Enzymic synthesis, purification, and fractionation of (2′-5′)-oligoadenylic acid. Methods in enzymology on CD-ROM/Methods in enzymology. 79(Pt B). 184–193. 22 indexed citations

Knight, M., P.J. Cayley, Robert H. Silverman, et al.. (1980). Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells. Nature. 288(5787). 189–192. 202 indexed citations

Bensinger, Thomas A., T. F. Zuck, Bert M. Tolbert, et al.. (1978). An enzymatic method for measurement of ascorbate-2-phosphate. Biochemical Medicine. 19(1). 118–126. 3 indexed citations

Baker, E. M., et al.. (1975). METABOLISM OF ASCORBIC ACID AND ASCORBIC‐2‐SULFATE IN MAN AND THE SUBHUMAN PRIMATE. Annals of the New York Academy of Sciences. 258(1). 72–80. 28 indexed citations

10.

Tolbert, Bert M., Mancourt Downing, Russell W. Carlson, M. Knight, & E. M. Baker. (1975). CHEMISTRY AND METABOLISM OF ASCORBIC ACID AND ASCORBATE SULFATE^*. Annals of the New York Academy of Sciences. 258(1). 48–69. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact